UNH vs ELV
UNH and ELV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | ELVElevance Health, Inc. |
|---|---|---|
| Market cap | $361.91B | $89.39B |
| P/E (TTM) | 23.1 | 17.6 |
| P/B | 10.96 | 2.00 |
| P/S | 0.8x | 0.5x |
| Dividend yield | 2.19% | 1.71% |
| Revenue | $449.66B(TTM) | $201.83B(TTM) |
| Revenue growth (YoY) | 11.8% | 12.5% |
| Net income | $15.88B(TTM) | $5.14B(TTM) |
| Earnings growth (YoY) | -16.3% | -5.3% |
| EPS, diluted | $17.52(TTM) | $23.55(TTM) |
| EBIT margin | 4.2% | 3.6% |
| ROE | 36.5% | 12.7% |
| ROIC | 20.3% | 9.4% |
| 1y total return | +23.8% | +34.7% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: UNH frente a ELV
| Métrica | UNH | ELV |
|---|---|---|
| Valor final | $34.1K | $36.3K |
| Retorno total | +240.7% | +262.6% |
| CAGR | +12.6% | +13.3% |
| Volatilidad | 30.0% | 31.0% |
| Sharpe | 0.41 | 0.42 |
| Sortino | 0.56 | 0.60 |
| Caída máxima | -61.4% | -50.4% |
Basado en 2600 días de negociación comunes, 2016-07-01 → 2026-11-03 · tasa libre de riesgo 4.21% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)